SEVETYS acquired by EURAZEO
Context
Eurazeo acquired a majority stake in Sevetys from Ardian, which had previously financed the group's initial rapid expansion. The transaction included a EUR250 million equity injection from Eurazeo to fuel a new phase of aggressive growth. The investment thesis focuses on consolidating the highly fragmented French veterinary market, which is protected by specific regulatory barriers regarding clinical governance and independence. Sevetys positions itself as a sovereign French alternative to global giants like IVC Evidensia and AniCura. Under Eurazeo's ownership, the group successfully completed approximately 100 acquisitions in 2022 alone, expanding its footprint into new regions such as the Rhone Valley and Grenoble.
SEVETYS, which reported an EBITDA margin of in 2022, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Founded in 2017, Sevetys is a leading French veterinary clinic group. It operates a network of over 150 sites across France, including major clusters inIle-de-France, Brittany, and the Loire Valley. The group differentiates itself through a "French model" of governance, ensuring that practicing veterinarians remain significant shareholders and maintain clinical independence while the group centralizes administrative and financial functions.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 07/2022 | ANDERA PARTNERS | GROUPE RESONANCE IMAGERIE | FRANCE | Radiology |
| 07/2022 | LATOUR CAPITAL | PHARMACIE LAFAYETTE - GROUPE HYGIE31 | FRANCE | Pharmacy |
| 06/2022 | ARDIAN | SIMAGO | FRANCE | Radiology |
| 06/2022 | TRITON PARTNERS | ESPERI CARE | FINLAND | Nursing Homes |
| 04/2022 | GROUPE BRUXELLES LAMBERT | AFFIDEA | NETHERLANDS | Radiology |
| 02/2022 | PARTNERS GROUP | Forefront Dermatology | UNITED STATES | Outpatient Care |
| 02/2022 | MEINE RADIOLOGIE | ALERIS - RADIOLOGY | SWEDEN | Radiology |
| 01/2022 | WREN HOUSE | VOYAGE CARE | UNITED KINGDOM | Nursing Homes |
| 12/2021 | VIVALTO PARTNERS / IK PARTNERS / MACSF / ARKEA CAPITAL / BNP PARIBAS DEVELOPPEMENT | VIVALTO SANTÉ | FRANCE | Clinics / Hospitals |
| 12/2021 | RAMSAY HEALTH CARE | ELYSIUM HEALTHCARE | UNITED KINGDOM | Clinics / Hospitals |
REFERENCES
Valuation range: EV 500M - 1.5b EUR
Revenue range: 100M - 200M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SEVETYS by EURAZEO are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Acquirer: eurazeo